Drug-Activated protein boosts memory
Researchers have made a breakthrough by genetically altering the LIMK1 (a protein crucial to memory) so that it can be controlled by rapamycin.
This study shows that it is possible to improve memory by manipulating the synaptic plasticity of the brain.
The engineered protein improved memory in animal models that had age-related cognitive decline. This could lead to innovative treatments for neuropsychiatric disorders like dementia. This ‘chemogenetic approach’, which combines genetics and chemical compounds, opens up new avenues for neurological research and treatment.
来源和详细信息：